.png)
.png)
CEO Update - 1 July 2024
I will watch the General Election this Thursday with great interest, like the rest of the country, and update you on the new ministers and members of Parliament next week. You can access the policy backgrounds of the main parties and view our webinar on what the campaign has taught us about what our sector should expect from the new parliament and government.
Shaping future leaders in biomanufacturing: insights from MAC LeaP
Over the past nine years, Dr Tony Bradshaw, Managing Director of Biosocius, has collected data from three distinct projects within the biotechnology sector. This effort has yielded unique and valuable insights that can help professionals thrive and build sustainable, fulfilling careers. By analysing behavioural profiles and consulting with industry experts, we can better understand the evolving demands of leadership in bioscience.
Why digital matters for neurodegeneration treatments
Molly Andrews of the UK Dementia Research Institute, Priya Kalia of SciTribe, and Miranda Weston-Smith of BioBeat highlight the urgent need for innovative digital solutions and investments in the accurate diagnosis and effective treatment of neurodegenerative diseases, as emphasised at BioBeat24.
CEO Update - 24 June 2024
In two Newscasts time, we will know the outcome of the UK General Election to be held on Thursday, 4 July. Join our webinar tomorrow at 1 pm where we will discuss what we have learned from the campaigns and manifestoes about potential future policies and people important for our sector after the result.
CEO Update - 17 June 2024
Last week saw the key parties launch their general election manifestoes. This week sees a set piece hosting debate with the core parties talking about their approach to science and innovation at a live hustings at the Royal Society.
Life sciences in the public eye: what can we learn from the manifestoes?
With fewer than twenty days to go and the manifestoes of the main parties now published, the BIA policy team pick apart what each party is pledging for the life science sector.
The evolving life sciences landscape
The life sciences sector in the UK has been the subject of significant attention over recent years. Activity in the sector has been spurred on by a multitude of drivers and its potential has also been frequently highlighted by the UK government.
CEO Update - 10 June 2024
UK General Election and what it might mean for the industry, including Labour's pledges on Brexit and business taxes. Upcoming events including the Cambridge Wide Open Day and the Life Science Leadership Summit. UK tech companies pitching at the London Stock Exchange and Amber Therapeutics securing $100 million in funding.
Women in Biotech Mentoring Programme: Dr Carolina Grandellis
In this interview, Dr Carolina Grandellis, Lead of the Earlham Institute Biofoundry, explores the profound impact of the BIA's Women in Biotech mentoring programme on her professional and personal life.
An urgent call for technical standards and metrics for engineering biology
There are currently very few technical standards and metrics that are specific and appropriate to the field of engineering biology. Across the innovation pipeline, there are opportunities for standards to support faster development and enable accelerated commercialisation of the bioeconomy. In response to this, an effort was undertaken with the objective of identifying key areas where standards and metrics would enable the growth of the global bioeconomy.